Gene: SYNC
Official Full Name: syncoilin, intermediate filament proteinprovided by HGNC
Gene Summary: This gene encodes a member of the intermediate filament family which contains an N-terminal head domain, followed by a central coiled-coil region and a short C-terminal tail. The protein is highly expressed in skeletal and cardiac muscle. The protein links the dystrophin associated protein complex (DAPC) to desmin filaments in muscle and may have a structural role in striated muscle. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04925 | SYNC Knockout cell line (HeLa) | Human | SYNC | 1:3~1:6 | Negative | Online Inquiry |
KO04926 | SYNC Knockout cell line (HEK293) | Human | SYNC | 1:3~1:6 | Negative | Online Inquiry |
KO04927 | SYNC Knockout cell line (A549) | Human | SYNC | 1:3~1:4 | Negative | Online Inquiry |
SYNC Gene Knockout Cell Lines are engineered cellular models that facilitate the study of gene function by selectively disrupting the SYNC gene. These cell lines serve as a powerful tool for researchers seeking to investigate the molecular mechanisms underlying gene expression and its implications in various biological processes. By employing cutting-edge CRISPR-Cas9 gene-editing technology, these knockout cell lines result in the complete or partial loss of function of the SYNC gene, enabling the assessment of phenotypic changes that occur in response to its absence.
The key functions of the SYNC Gene Knockout Cell Lines allow researchers to mimic disease states, study regulatory pathways, and assess cellular responses in an in vitro environment. This is particularly valuable in elucidating the mechanisms of diseases that may be linked to dysregulation of the SYNC gene, thus contributing significantly to our understanding of pathology and potential therapeutic targets.
In research and clinical settings, these knockout cell lines are instrumental for drug discovery, toxicology studies, and biomarker identification, allowing scientists to evaluate the efficacy of compounds in a controlled environment. The ability to reproduce specific genetic alterations provides insights that are critical for personalized medicine approaches and the advancement of gene therapies.
What sets SYNC Gene Knockout Cell Lines apart from traditional models is their precision and specificity, with unmatched reliability and reproducibility in experimental settings. Unlike other methods that may result in off-target effects, the CRISPR-Cas9 approach offers a clean knockout, ensuring that the observed effects are directly attributable to the targeted gene disruption.
For researchers, clinicians, and biotech companies focused on translational research, investing in SYNC Gene Knockout Cell Lines offers a competitive edge in the race to uncover innovative treatments and therapies. These products not only save time and resources but also provide an indispensable resource for advancing scientific knowledge.
At our company, we pride ourselves on delivering high-quality, scientifically validated products backed by extensive research and expert support, making us a trusted partner in your quest for groundbreaking discoveries in genetics and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.